Zobrazeno 1 - 10
of 39
pro vyhledávání: '"G W Carter"'
Autor:
G. W. Carter
Publikováno v:
Physical Review D. 67
We compute the axial vector current, form factor, and coupling for quarks in the instanton liquid model with two light flavors. Non-local current corrections are derived, as required by the effective 't Hooft interaction. We obtain a pion-mediated ax
We phenomenologically study whether partonic collisions responsible for the growth of hadron-hadron cross sections at high energy can be ascribed to instanton-induced processes. Although non-perturbative in nature, these interactions occur at the sem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ae8dfefb99c7ba0f6fca9172afe67d
http://arxiv.org/abs/hep-ph/0112036
http://arxiv.org/abs/hep-ph/0112036
Autor:
K W, Mollison, T A, Fey, D M, Gauvin, R M, Kolano, M P, Sheets, M L, Smith, M, Pong, N M, Nikolaidis, B C, Lane, J M, Trevillyan, J, Cannon, K, Marsh, G W, Carter, Y S, Or, Y W, Chen, G C, Hsieh, J R, Luly
Publikováno v:
The Journal of investigative dermatology. 112(5)
T lymphocytes play a critical part in inflammatory skin diseases but are targeted by available therapies that have only partial efficacy, significant side-effects, or both. Because psoriasis, atopic dermatitis, and allergic contact hypersensitivity a
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 25(9)
An in vitro glucuronidation assay was used to optimize a series of N-hydroxyurea-containing 5-lipoxygenase inhibitors for metabolic stability. The glucuronidation of these compounds in cynomolgus monkey microsomes followed Michaelis-Menten kinetics a
Autor:
R L, Bell, R R, Harris, P E, Malo, J B, Bouska, T K, Shaughnessy, K I, Hulkower, C D, Brooks, G W, Carter
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 280(3)
Our primary goal has been to discover leukotriene biosynthesis inhibitors with characteristics that are appropriate for use as clinical agents. The success of the use of zileuton in the treatment of asthma led us to explore further the use of the N-h
Autor:
K I, Hulkower, E R, Otis, J, Li, B W, Ennis, D J, Cugier, R L, Bell, G W, Carter, K B, Glaser
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 280(2)
These studies examined the signal transduction mechanisms by which prostaglandin (PG) E2 production can occur in human amnionic WISH cells in response to the stimuli okadaic acid, interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, phorbol-12-
Autor:
R L, Bell, R R, Harris, J B, Bouska, K I, Hulkower, J, Moore, P, Bhatia, P E, Malo, T, Kalosa, C D, Brooks, G W, Carter
Publikováno v:
Advances in experimental medicine and biology. 433
Autor:
D H, Albert, R G, Conway, T J, Magoc, P, Tapang, D A, Rhein, G, Luo, J H, Holms, S K, Davidsen, J B, Summers, G W, Carter
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(3)
ABT-299 is an aqueous soluble prodrug that is converted rapidly in vivo to A-85783, a novel, highly potent, specific platelet activating factor (PAF) antagonist. The K, for inhibiting PAF binding to rabbit platelet membranes is 3.9 and 0.3 nM for hum
Publikováno v:
Advances in experimental medicine and biology. 416
In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors
Publikováno v:
Canadian journal of physiology and pharmacology. 73(5)
Les inhibiteurs selectifs de l'oxyde nitrique synthase (NOS) de type II ont plusieurs applications therapeutiques possibles, incluant le traitement de la septicemie, du diabete et des maladies autoimmunes. On a examine la capacite de deux nouveaux in